Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Abbott Provides the Right Laboratory Solutions for Imperial College Healthcare

Published: Friday, November 30, 2012
Last Updated: Friday, November 30, 2012
Bookmark and Share
Abbott’s managed service contract provides trusts with a cost-effective, guaranteed service.

The Division of Infection and Immunity at Imperial College Healthcare NHS Trust is benefitting from a managed service contract with Abbott, ensuring an efficient and reliable service for one of Britain’s largest NHS trusts.

Consultant Virologist Mark Atkins explained: “The Trust has a catchment of almost 1.5 million people, and so it is vital that all our equipment functions as it should, or a backlog will quickly develop. We have been working with Abbott for many years, and we know we can rely on our ARCHITECT® platforms and other Abbott instruments to perform as expected. The full automation offered by these systems gives us the throughput and flexibility to deliver a high quality, efficient service for our clinicians; the lab simply wouldn’t work without them.”

“The benefits of our managed service contract were clearly demonstrated during the recent merger of microbiology, virology and immunology services into a single blood sciences group within the Trust. Our Abbott facilities manager was instrumental in this, co-ordinating the transfer of equipment so that it did not interrupt services or have an impact on patients. The Abbott team also helped us to develop more efficient combined workflows, listening to our needs and delivering solutions that matched our requirements. For example, we are now running syphilis assays on our ARCHITECT systems, meaning all antenatal samples can be run on a single analyzer, and we can also run a high performance HIV test on this platform.”

Rebecca Stalham, Marketing and Contracts Director at Abbott, added: “A managed service contract provides trusts with a cost-effective, guaranteed service, allowing laboratory staff to focus on high value work which ultimately leads to better patient care, and we are happy that this model is working so well for Imperial College Healthcare.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More Than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Abbott to Acquire Alere for $5B
Acquisition broadens Abbott's diagnostics footprint by providing access to new product applications, channels and geographies.
Monday, February 01, 2016
Scientific News
Shedding Light on HIV Vaccine Design
Broadly speaking - Mathematical modelling of host-pathogen coevolution sheds light on HIV vaccine design.
AACC 2016 Sees Clinical Chemistry Labs Drive Precision Medicine Offerings
Biomarker assays to enable precision medicine and risk assessment, mass spec-based tests designed for use in clinical labs large and small, and liquid biopsy technology captured the spotlight at the AACC annual meeting.
Automated Patch Clamping Trends
Learn more about current practices, preferences and metrics in ion channel drug screening using APC technology.
Emerging Model of Cancer
Cancer acts cooperatively, making individual decisions but acting in unison; this insight is being used to create a computer model of cancer.
Biological Barcodes Using CRISPR
Using genome editing tools, researchers are getting closer to understand differentiation of various cell types during development.
Controlling DNA Repair
Scientists discover that DNA repair outcomes following CRISPR-Cas9 cleaving are non-random and can be harnessed to produce desired effects.
Demonstrating LNP Delivery of CRISPR Components
Intellia has presented data demonstrating in vivo gene editing ising liquid nanoparticles (LNPs) to deliver CRISPR/Cas9.
Decades Old Chemicals Linked to Current Increased Autism Risk
The chemcials - organochlorines - were banned in the US in 1977 but their side effects are still being seen.
FINCH Filgotinib Phase 3 Program Initiated
Galapagos NV reports the initiation of the FINCH global Phase 3 program in rheumatoid arthritis patient populations.
Enzyme that Triggers Cell Demise in ALS Identified
Scientists from Harvard have identified a key instigator of nerve cell damage in people with amyotrophic lateral sclerosis (ALS).
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!